Flesh-Eating Zombie Drug Hits Midwest (Still Not a Joke)

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Last month, krokodil, a highly addictive drug that eats through human skin, made its first known appearance in the United States, with two cases reported in Arizona. Now, use of krokodil—which has been nicknamed the “zombie drug“—has spread to the Midwest. The Herald-News reports that five people have been treated for symptoms associated with krokodil use at the Provena Saint Joseph Medical Center in Joliet, Illinois, which is located about 40 miles from the Windy City.

Dr. Abhin Singla, director of addiction services at the Joliet hospital, told CBS 2 that one of the patients was a 25-year-old longterm heroin user who started using krokodil about a month ago. Singla notes, “When she came in, she had the destruction that occurs because of this drug, over 70 percent of her lower body.”

As we reported last month, krokodil, which is Russian slang for Desomorphine, has a similar effect to heroin, but it is significantly cheaper and easier to make. Its main ingredients are codeine, iodine, red phosphorous, paint thinner, gasoline, and hydrochloric acid. It’s far more addictive and deadly; krokodil users tend to only live two or three years. When the drug is injected into the skin, it often causes gangrene, forcing the skin to rot away, and causes speech problems and erratic muscle movements. Singla told the Beacon-News, “If you want to kill yourself, (using) this is the way to do it.” (For gruesome and totally NSFW images of the health effects of krokodil, go here.)

Singla told the Herald-News that the krokodil users believed that they were getting heroin and were given the other drug instead. Most said they obtained the drug in Chicago—not Joliet. Three of the patients were “middle-class white women in their early to mid-20s” and the other two were men, one 22 and the other 32, with arm wounds, according to the paper. The 25-year-old remains in intensive care, and “two others have left the hospital against medical advice because they were afraid of prosecution.” Krokodil is a new synthetic drug, so it is not yet a controlled substance, according to a DEA spokesperson.

Until this fall, the drug had never been seen before in the United States. However, the drug has been prevalent in Russia. In the first few months of 2011 alone, the Russia’s Federal Drug Control Service confiscated 65 million doses of the drug.

The Drug Enforcement Agency (DEA) is not currently investigating the reported emergence of krokodil in the US. “We have not received any sort of specimen in any of our labs,” DEA spokeswoman Dawn Dearden tells Mother Jones. But, she adds, “we’re keeping an eye out on the trends across the country, and if and when we need to get involved, we certainly will.”

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate